Jul

29

Catalent Enters into Strategic Partnership with Editas Medicine to Support Gene Editing Medicine Pipeline

Jul

27

Editas Medicine Appoints Gad Berdugo as Chief Business Officer

Jul

23

Editas Medicine to Host Conference Call Discussing Second Quarter 2020 Results and Corporate Update